Caption Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,000
| Closed | -$274K | – | 901 |
|
|
2024
Q4 | $274K | Buy |
+20,000
| New | +$274K | ﹤0.01% | 357 |
|
|
2024
Q3 | – | Sell |
-38,300
| Closed | -$937K | – | 723 |
|
|
2024
Q2 | $937K | Buy |
+38,300
| New | +$937K | 0.01% | 152 |
|
|
2024
Q1 | – | Sell |
-57,845
| Closed | -$1.11M | – | 753 |
|
|
2023
Q4 | $1.11M | Buy |
+57,845
| New | +$1.11M | 0.01% | 145 |
|
|
2023
Q3 | – | Sell |
-85,017
| Closed | -$1.97M | – | 674 |
|
|
2023
Q2 | $1.97M | Buy |
+85,017
| New | +$1.97M | 0.03% | 73 |
|
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$378K | – | 778 |
|
|
2022
Q1 | $378K | Buy |
+15,000
| New | +$378K | ﹤0.01% | 345 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 541 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 515 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 474 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 448 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 400 |
|
|
2019
Q2 | – | Sell |
-35,000
| Closed | -$1.16M | – | 376 |
|
|
2019
Q1 | $1.16M | Buy |
+35,000
| New | +$1.16M | 0.06% | 67 |
|